Archives
Biotin-XX Tyramide Reagent: Precision Cell Surface Labeling
2026-05-05
Biotin-XX Tyramide Reagent (biotin-LC-LC-tyramide) empowers researchers to map cell surface proteomes with unmatched specificity and sensitivity, thanks to its membrane-impermeant design. Learn how to maximize tyramide signal amplification and overcome serotonin-mediated inhibition for high-confidence neuroscience and spatial proteomics.
Vemurafenib (PLX4032): Systems Biology Insights in Melanoma
2026-05-05
Explore how Vemurafenib (PLX4032) enables advanced systems biology in melanoma research, focusing on resistance mechanisms and multi-omics integration. This article delivers a unique, workflow-driven perspective for cancer biology laboratories.
Omeprazole (A2845): Technical Guidance for Acid Secretion Re
2026-05-04
Omeprazole, a potent H+,K+-ATPase inhibitor (SKU A2845), enables controlled inhibition of gastric acid secretion in basic and applied research settings. This reagent provides a defined, reproducible means to model antiulcer activity and gastric acid-related disorders but is not intended for diagnostic or clinical use. Proper handling and protocol adherence are essential for consistent results.
rTMS Promotes Amyloid Clearance via GABAergic Cx3cl1-Cx3cr1
2026-05-04
This study demonstrates that repetitive transcranial magnetic stimulation (rTMS) enhances cognitive recovery in Alzheimer's disease (AD) mouse models by activating GABAergic neurons and upregulating the Cx3cl1-Cx3cr1 signaling axis. The findings reveal a non-invasive molecular mechanism driving microglial-mediated amyloid beta clearance, supporting the development of targeted therapies for AD.
G007-LK Tankyrase 1/2 Inhibitor: Precision in Wnt Pathway Re
2026-05-03
G007-LK empowers researchers to dissect Wnt/β-catenin and Hippo signaling with nanomolar selectivity, enabling robust APC mutation colorectal cancer and hepatocellular carcinoma studies. This guide delivers workflow-optimized protocols, troubleshooting strategies, and data-backed insight into leveraging G007-LK’s unique advantages for experimental success.
Amyloid Beta-Peptide (1-40) (human): Benchmarks and Research
2026-05-02
Amyloid Beta-Peptide (1-40) (human) is a synthetic peptide central to Alzheimer's disease research. It models amyloid fibril formation and neurotoxicity with well-characterized physical and biological properties. APExBIO provides a rigorously specified version (A1124), supporting robust, reproducible experiments.
MCL-1’s Canonical Anti-Apoptotic Role in Breast Cancer Depen
2026-05-02
This study rigorously demonstrates that established breast tumors are dependent on MCL-1 primarily for its canonical anti-apoptotic function. The findings clarify therapeutic targeting strategies for MCL-1 and highlight implications for BH3-mimetic drug development in breast cancer.
Omeprazole (A2845): Research-Grade H+,K+-ATPase Inhibitor Gu
2026-05-01
Omeprazole (SKU A2845) is a high-purity H+,K+-ATPase inhibitor designed for precise gastric acid secretion and antiulcer activity studies. It is best suited for controlled laboratory workflows modeling gastric acid-related disorders, not for diagnostic or clinical use. Its optimal use relies on attention to solubility and stability, as detailed below.
Cinoxacin: In Vitro Activity and Resistance in Gram-Negative
2026-04-30
This study provides a rigorous, quantitative evaluation of Cinoxacin's antibacterial activity against aerobic Gram-negative bacilli, establishing its efficacy spectrum and resistance dynamics. The findings clarify both methodological standards and critical limitations for researchers investigating urinary tract and resistance mechanisms.
AMPK’s Dual Regulatory Role in Autophagy Under Energy Stress
2026-04-30
This study challenges the established model of AMPK as a straightforward activator of autophagy during energy deprivation, demonstrating instead that AMPK suppresses ULK1-dependent autophagy initiation while preserving autophagy machinery for later recovery. These findings refine our understanding of cellular energy management and provide a framework for precise modulation of autophagy in metabolic research.
YBX1 and SHANK3: DNA Methylation Dynamics in Schizophrenia
2026-04-29
This study uncovers a DNA methylation-dependent mechanism regulating SHANK3 expression in schizophrenia, mediated by the transcription factor YBX1 in cortical interneurons. The findings establish SHANK3 promoter hypermethylation as a potential biomarker in peripheral blood and clarify cell-type–specific gene regulation relevant to disease pathogenesis.
Calcium’s Effect on Amyloid Beta Aggregation: Insights from
2026-04-29
This study employs supercritical angle Raman and fluorescence spectroscopy to dissect the direct effects of CaCl₂ on amyloid beta aggregation at membrane surfaces. The findings clarify calcium’s nuanced, time-dependent influence on peptide aggregation and membrane protection, deepening understanding of amyloid-driven neurotoxicity in Alzheimer’s disease and refining in vitro modeling approaches.
Structure-Based Screening Identifies NSP15 Inhibitors in SAR
2026-04-28
This study applies structure-based virtual screening to identify natural product inhibitors of SARS-CoV-2 non-structural protein 15 (NSP15), highlighting thymopentin and oleuropein as potent candidates. The findings provide a foundation for targeted antiviral development by demonstrating stable inhibitor-NSP15 interactions in silico.
Sunitinib as a Multi-Targeted RTK Inhibitor: RCC Research Wo
2026-04-28
Sunitinib's precision as a multi-targeted receptor tyrosine kinase inhibitor empowers robust cancer research, especially in renal cell carcinoma (RCC) and angiogenesis studies. This guide translates cutting-edge findings into actionable protocols, explores synergistic strategies to overcome resistance, and equips scientists with troubleshooting insights for reproducibility.
Dual-Action Inhibition and Dephosphorylation of p38α MAPK
2026-04-27
This study demonstrates that certain kinase inhibitors, including those like BIRB 796, not only block p38α MAPK activity but also accelerate its dephosphorylation by stabilizing a phosphatase-accessible conformation. These findings provide mechanistic insight into kinase-phosphatase interplay and suggest new strategies for designing selective inhibitors in inflammation research.
608 records 23/41 page Previous Next First page 上5页 2122232425 下5页 Last page